Ameriprise
TYRA icon

Ameriprise’s Tyra Biosciences TYRA Stock Holding History

Ameriprise’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$540K Sell
16,920
-127,980
-88% -$4.23M ﹤0.01% 3639
2026
Q1 		$5.55M Buy
144,900
+90,275
+165% +$2.92M ﹤0.01% 2362
2025
Q4 		$1.44M Sell
54,625
-32,482
-37% -$597K ﹤0.01% 3169
2025
Q3 		$1.22M Buy
87,107
+6,505
+8% +$74.2K ﹤0.01% 3258
2025
Q2 		$771K Buy
+80,602
New +$766K ﹤0.01% 3370

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Ameriprise's TYRA Position: Q2 2026 in Review

Ameriprise reduced its Tyra Biosciences (TYRA) stake by 88% in Q2 2026, selling an estimated $4.23M and leaving 16,920 shares worth $540K. The position accounts for ﹤0.01% of the portfolio, ranked #3639.

Ameriprise first reported a position in TYRA in Q2 2025 and has held it in 5 quarters since. The position peaked at $5.55M in Q1 2026. 168 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Ameriprise held 16,920 shares of Tyra Biosciences worth $540K as of Q2 2026.
  • Ameriprise sold 127,980 Tyra Biosciences shares in Q2 2026, an estimated $4.23M.
  • Tyra Biosciences made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #3639 holding.
  • Ameriprise first reported a position in Tyra Biosciences in Q2 2025 and has held it in 5 quarters since.
  • Ameriprise's Tyra Biosciences position peaked at $5.55M in Q1 2026.
  • 168 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.